Submission of Swiss BE trial information form now mandatory
This article was originally published in SRA
Executive Summary
Switzerland’s therapeutic products regulatory authority, Swissmedic, has reminded sponsors of generic medicines that all applications must now comply with its updated marketing authorisation rules, which includes the submission of a new bioequivalence trial information form1.